Paper30286151
T Cell Leukemia/Lymphoma 1A is essential for mouse epidermal keratinocytes proliferation promoted by insulin-like growth factor 1.
Bresin A and 9 others. PLoS One, 2018. Cited by 5 papers, by iCite.
Cite this record
ConductScience Library. T Cell Leukemia/Lymphoma 1A is essential for mouse epidermal keratinocytes proliferation promoted by insulin-like growth factor 1. Papers, record 30286151. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/30286151
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- T Cell Leukemia/Lymphoma 1A is essential for mouse epidermal keratinocytes proliferation promoted by insulin-like growth factor 1.
- PubMed
Topics20
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Cell Proliferation | Major topic |
| Insulin-Like Growth Factor I | Major topic |
| Keratinocytes | Major topic |
| Proto-Oncogene Proteins | Major topic |
| Animals | |
| Apoptosis | |
| Cell Differentiation | |
| Disease Models, Animal | |
| Epidermis | |
| Filaggrin Proteins | |
| Gene Expression Regulation, Neoplastic | |
| Hair Follicle | |
| Leukemia, Lymphocytic, Chronic, B-Cell | |
| MAP Kinase Signaling System | |
| Mice | |
| Mice, Inbred C57BL | |
| Mice, Transgenic | |
| Skin | |
| Stem Cell Niche | |
| p38 Mitogen-Activated Protein Kinases |
Source PubMed
References51
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 15340077 | Protein kinase Cdelta regulates keratinocyte death and survival by regulating activity and subcellular localization of a p38delta-extracellular signal-regulated kinase 1/2 complex. | Mol Cell Biol | 2004 | https://conductscience.org/library/papers/15340077 | PubMed |
| 2 | 16537911 | Insulin-like growth factor 1 receptor signaling regulates skin development and inhibits skin keratinocyte differentiation. | Mol Cell Biol | 2006 | https://conductscience.org/library/papers/16537911 | PubMed |
| 3 | 18000402 | Ras/Erk MAPK signaling in epidermal homeostasis and neoplasia. | Cell Cycle | 2007 | https://conductscience.org/library/papers/18000402 | PubMed |
| 4 | 17901877 | TCL1 promotes blastomere proliferation through nuclear transfer, but not direct phosphorylation, of AKT/PKB in early mouse embryos. | Cell Death Differ | 2008 | https://conductscience.org/library/papers/17901877 | PubMed |
| 5 | 19755673 | Chronic lymphocytic leukemia of Emu-TCL1 transgenic mice undergoes rapid cell turnover that can be offset by extrinsic CD257 to accelerate disease progression. | Blood | 2009 | https://conductscience.org/library/papers/19755673 | PubMed |
| 6 | 15479728 | Impaired T- and B-cell development in Tcl1-deficient mice. | Blood | 2005 | https://conductscience.org/library/papers/15479728 | PubMed |
| 7 | 15654976 | Fos and jun proteins are specifically expressed during differentiation of human keratinocytes. | J Invest Dermatol | 2005 | https://conductscience.org/library/papers/15654976 | PubMed |
| 8 | 23762562 | AP1 transcription factors in epidermal differentiation and skin cancer. | J Skin Cancer | 2013 | https://conductscience.org/library/papers/23762562 | PubMed |
| 9 | 20445555 | PKC-delta and -eta, MEKK-1, MEK-6, MEK-3, and p38-delta are essential mediators of the response of normal human epidermal keratinocytes to differentiating agents. | J Invest Dermatol | 2010 | https://conductscience.org/library/papers/20445555 | PubMed |
| 10 | 7622446 | The regulation of AP-1 activity by mitogen-activated protein kinases. | J Biol Chem | 1995 | https://conductscience.org/library/papers/7622446 | PubMed |
| 11 | 24599959 | p38δ regulates p53 to control p21Cip1 expression in human epidermal keratinocytes. | J Biol Chem | 2014 | https://conductscience.org/library/papers/24599959 | PubMed |
| 12 | 7809072 | Identification of the TCL1 gene involved in T-cell malignancies. | Proc Natl Acad Sci U S A | 1994 | https://conductscience.org/library/papers/7809072 | PubMed |
| 13 | 10983986 | The protooncogene TCL1 is an Akt kinase coactivator. | Mol Cell | 2000 | https://conductscience.org/library/papers/10983986 | PubMed |
| 14 | 17448993 | Zfx controls the self-renewal of embryonic and hematopoietic stem cells. | Cell | 2007 | https://conductscience.org/library/papers/17448993 | PubMed |
| 15 | 9520462 | Deregulated expression of TCL1 causes T cell leukemia in mice. | Proc Natl Acad Sci U S A | 1998 | https://conductscience.org/library/papers/9520462 | PubMed |
| 16 | 23940776 | Functional analysis of Tcl1 using Tcl1-deficient mouse embryonic stem cells. | PLoS One | 2013 | https://conductscience.org/library/papers/23940776 | PubMed |
| 17 | 23226615 | The role of the c-Jun N-terminal Kinase signaling pathway in skin cancer. | Am J Cancer Res | 2012 | https://conductscience.org/library/papers/23226615 | PubMed |
| 18 | 12181493 | TCL1 participates in early embryonic development and is overexpressed in human seminomas. | Proc Natl Acad Sci U S A | 2002 | https://conductscience.org/library/papers/12181493 | PubMed |
| 19 | 17360849 | Proto-oncogene TCL1: more than just a coactivator for Akt. | FASEB J | 2007 | https://conductscience.org/library/papers/17360849 | PubMed |
| 20 | 16341048 | TCL1 shows a regulated expression pattern in chronic lymphocytic leukemia that correlates with molecular subtypes and proliferative state. | Leukemia | 2006 | https://conductscience.org/library/papers/16341048 | PubMed |
Cited by2
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 5 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 34771618 | The Modes of Dysregulation of the Proto-Oncogene T-Cell Leukemia/Lymphoma 1A. | Cancers (Basel) | 2021 | https://conductscience.org/library/papers/34771618 | PubMed |
| 31564197 | The TCL1 function revisited focusing on metabolic requirements of stemness. | Cell Cycle | 2019 | https://conductscience.org/library/papers/31564197 | PubMed |
Genes9
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| CASP3 | 836 | PubTator's text mining | https://conductscience.org/library/genes/836 | NCBI Gene |
| FLG | 2312 | PubTator's text mining | https://conductscience.org/library/genes/2312 | NCBI Gene |
| FOS | 2353 | PubTator's text mining | https://conductscience.org/library/genes/2353 | NCBI Gene |
| IGF1 | 3479 | PubTator's text mining | https://conductscience.org/library/genes/3479 | NCBI Gene |
| JUN | 3725 | PubTator's text mining | https://conductscience.org/library/genes/3725 | NCBI Gene |
| KRT14 | 3861 | PubTator's text mining | https://conductscience.org/library/genes/3861 | NCBI Gene |
| KRT72 | 140807 | PubTator's text mining | https://conductscience.org/library/genes/140807 | NCBI Gene |
| PARP1 | 142 | PubTator's text mining | https://conductscience.org/library/genes/142 | NCBI Gene |
| TCL1A | 8115 | PubTator's text mining | https://conductscience.org/library/genes/8115 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/30286151
GET https://conductscience.org/api/papers/v1/30286151/references?page=2